KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) EBIAT (2016 - 2025)

Historic EBIAT for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $5.1 billion.

  • Johnson & Johnson's EBIAT rose 4911.1% to $5.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $26.8 billion, marking a year-over-year increase of 9055.88%. This contributed to the annual value of $26.8 billion for FY2025, which is 9055.88% up from last year.
  • Johnson & Johnson's EBIAT amounted to $5.1 billion in Q4 2025, which was up 4911.1% from $5.2 billion recorded in Q3 2025.
  • Over the past 5 years, Johnson & Johnson's EBIAT peaked at $26.0 billion during Q4 2023, and registered a low of -$491.0 million during Q2 2023.
  • In the last 5 years, Johnson & Johnson's EBIAT had a median value of $4.8 billion in 2022 and averaged $5.6 billion.
  • Its EBIAT has fluctuated over the past 5 years, first plummeted by 10953.58% in 2023, then surged by 76293.28% in 2024.
  • Johnson & Johnson's EBIAT (Quarter) stood at $3.7 billion in 2021, then grew by 21.57% to $4.5 billion in 2022, then dropped by 7.31% to $4.1 billion in 2023, then decreased by 16.97% to $3.4 billion in 2024, then skyrocketed by 49.11% to $5.1 billion in 2025.
  • Its EBIAT stands at $5.1 billion for Q4 2025, versus $5.2 billion for Q3 2025 and $5.5 billion for Q2 2025.